Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
2-Trifluoro-N-((1R
nonapoptotic cell death in oncogenic-RAS-harboring cancer cells
CYP2C9 and CYP2C19 Sacchrosomes™
Gadodiamide itself produces lesions in the central cerebellar regions resembling in character and severity those produced by the gadodiamide formulation
GBR 12935 Catalog No.:M8659-2 2-Trifluoro-N-((1RGBR 12935 is a piperazine derivative which is a potent and selective dopamine reuptake inhibitor. It was originally developed in its 3H radiolabelled form for the purpose of mapping the distribution of dopaminergic neurons in the brain by selective labelling of dopamine transporter proteins. This has led to potential clinical uses in the diagnosis of Parkinson's disease, although selective radioligands such as Ioflupane (I) are now available for this